CORC

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文
BLOOD, 2018-11-29
作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
BLOOD, 2018-11-29
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:15/0  |  提交时间:2020/01/03
Preliminary Results from a Phase I, First-in-Human Study of YY-20394, a Highly Selective and Highly Potent PI3K delta Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies 会议论文
BLOOD, 2018-11-29
作者:  Qi, Junyuan;  Song, Yuqin;  Jiang, Bo;  Li, Jianyong;  Tu, Meifeng
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS) 会议论文
BLOOD, 2016-12-02
作者:  Hu, Shaoxuan;  Song, Yuqin;  Li, Yufu;  Sun, Xiuhua;  Su, Liping
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace